RIFART - RIFART

AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA0 个研究点开始时间: 2008年1月8日最近更新: 2012年7月17日

适应症

试验速览

暂无简介。

•We will enrol consecutive patients presenting at the clinical centres constituting the network, with a diagnosis of tuberculosis (presumptive or conclusive diagnosis) and HIV infection, with CD4 cell counts Saranno arruolati consecutivamente soggetti osservati presso i centri clinici partecipanti allo studio con diagnosi di tubercolosi (confermata o presuntiva) e co-infezione da HIV, and peripheral CD4 cell counts < 350 / cmm (if naive for antiretroviral therapy) of < 500 / cmm (if being already treated with antiretroviral drugs), who are able to provide written informed consent.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) yes
•F.1.3.1 Number of subjects for this age range

•Payients will not be eligible for the study if presentino with medical conditions (including allergy or poor tolerance to the study drugs, or infections which are resistano to any of the study drugs) contraindicating the use of one or more of the study drugs.

发起方

AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA